l9n/ Mississippi

2024 Regular Session

Senate Bill 2145

Defending Affordable Prescription Drug Costs Act; enact to prohibit discriminating against 340B drug discount program entities.

Did not become law. It stopped in the House of Representatives's Drug Policy Committee on April 2, 2024. The 2024 session has ended.

What it does

The synopsis the Legislature published with the bill.

AN ACT TO BE KNOWN AS THE DEFENDING AFFORDABLE PRESCRIPTION DRUG COSTS ACT; TO PROVIDE DEFINITIONS FOR THE PURPOSE OF THE ACT; TO PROHIBIT HEALTH INSURANCE ISSUERS, PHARMACY BENEFIT MANAGERS AND OTHER THIRD-PARTY PAYORS AND DRUG MANUFACTURERS AND DISTRIBUTORS FROM ENGAGING IN CERTAIN DISCRIMINATORY ACTIONS RELATING TO ENTITIES THAT ARE PARTICIPATING OR AUTHORIZED TO PARTICIPATE IN THE FEDERAL 340B DRUG DISCOUNT PROGRAM; TO PROVIDE THAT THE COMMISSION OF ANY ACT PROHIBITED BY THIS ACT IS CONSIDERED A VIOLATION OF THE CONSUMER PROTECTION ACT; TO AMEND SECTION 75-24-5, MISSISSIPPI CODE OF 1972, TO CONFORM TO THE PRECEDING PROVISION; AND FOR RELATED PURPOSES.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

Its course

February 2 to April 2, 2024, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

Each committee stop sits inside its chamber.

Every action6 actions on 6 days

In the SenateFeb 2 to Mar 1239 days

Public Health and WelfareFeb 2 to Feb 2826 days

In the House of RepresentativesMar 12 to Apr 2 · stopped21 days

Drug PolicyMar 18 to Apr 2 · stopped15 days

Text

Each version as the Legislature printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the Legislature published it is below.

In the Senate Feb 2 – Mar 12

  1. Referred to the Senate committee on Public Health and Welfare
  2. Reported from committee in the Senate: title sufficient, do pass
  3. Passed the Senate

In the House of Representatives Mar 13 – Apr 2

  1. Sent to the House
  2. Referred to the House committees on Drug Policy and on Public Health and Human Services
  3. Died in committee in the House
All 6 actions, as published